Moderators of fluoxetine treatment response for children and adolescents with comorbid depression and substance use disorders

Journal of Substance Abuse Treatment

Volumn 42, Issue 4, 2012, Pages 366-372

  Hirschtritt, Matthew E ^a   Pagano, Maria E ^b,c   Christian, Kelly M ^d   McNamara, Nora K ^b   Stansbrey, Robert J ^b   Lingler, Jacqui ^b   Faber, Jon E ^b   Demeter, Christine A ^b   Bedoya, Denise ^b   Findling, Robert L ^b,c  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Adolescents; Alcohol; Depression; Dysthymia; Fluoxetine; Marijuana; Mediators; Moderators; Substance abuse

Indexed keywords

ALCOHOL; CANNABIS; FLUOXETINE; PLACEBO;

ADOLESCENT; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; CANNABIS ADDICTION; CHILD; CHILDHOOD DISEASE; CHRONIC DISEASE; CHRONICITY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SUBSTANCE ABUSE; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ALCOHOLISM; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CHILD; CHRONIC DISEASE; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FLUOXETINE; HUMANS; MALE; MARIJUANA ABUSE; MOTIVATION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SUBSTANCE-RELATED DISORDERS;

EID: 84860369937     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2011.09.010     Document Type: Article

References (40)

1. Aiken L.S., West S.G. Multiple regression: Testing and interpreting interactions 1991, Sage Publications, Thousand Oaks, CA.
2. American Statistical Association Ethical guidelines for statistical practice 1999, Author, Alexandria, VA.
3. Beck A.T., Brown G., Berchick R.J., Stewart B.L., Steer R.A. Relationship between hopelessness and ultimate suicide: A replication with psychiatric outpatients. American Journal of Psychiatry 1990, 147:190-195.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 1961, 4:561-571.
5. Blom M.B., Spinhoven P., Hoffman T., Jonker K., Hoencamp E., Haffmans P.M., et al. Severity and duration of depression, not personality factors, predict short term outcome in the treatment of major depression. Journal of Affective Disorders 2007, 104:119-126.
6. Bridge J.A., Birmaher B., Iyengar S., Barbe R.P., Brent D.A. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. The American Journal of Psychiatry 2009, 166:42-49.
7. Chinet L., Plancherel B., Bolognini M., Bernard M., Laget J., Daniele G., et al. Substance use and depression. Comparative course in adolescents. European Child & Adolescent Psychiatry 2006, 15:149-155.
8. Cornelius J.R., Bukstein O.G., Wood D.S., Kirisci L., Douaihy A., Clark D.B. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addictive Behaviors 2009, 34:905-909.
9. Curry J., Rohde P., Simons A., Silva S., Vitiello B., Kratochvil C., et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:1427-1439.
10. Denicoff K.D., Smith-Jackson E.E., Disney E.R., Suddath R.L., Leverich G.S., Post R.M. Preliminary evidence of the reliability and validity of the prospective Life-Chart Methodology (LCM-p). Journal of Psychiatric Research 1997, 31:593-603.
11. Donohue B., Azrin N.H., Strada M.J., Silver N.C., Teichner G., Murphy H. Psychometric evaluation of self- and collateral timeline follow-back reports of drug and alcohol use in a sample of drug-abusing and conduct-disordered adolescents and their parents. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors 2004, 18:184-189.
12. Emslie G.J., Heiligenstein J.H., Wagner K.D., Hoog S.L., Ernest D.E., Brown E., et al. Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41:1205-1215.
13. Emslie G.J., Rush A.J., Weinberg W.A., Kowatch R.A., Carmody T., Mayes T.L. Fluoxetine in child and adolescent depression: Acute and maintenance treatment. Depression and Anxiety 1998, 7:32-39.
14. Emslie G.J., Rush A.J., Weinberg W.A., Kowatch R.A., Hughes C.W., Carmody T., et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry 1997, 54:1031-1037.
15. Evans S.M., Levin F.R., Brooks D.J., Garawi F. A pilot double-blind treatment trial of memantine for alcohol dependence. Alcoholism Clinical and Experimental Research 2007, 31:775-782.
16. Findling R.L., Pagano M.E., McNamara N.K., Stansbrey R.J., Faber J.E., Lingler J., et al. The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: A pilot randomized placebo-controlled trial. Child and Adolescent Psychiatry and Mental Health 2009, 3:11.
17. Fisher S.L., Bucholz K.K., Reich W., Fox L., Kuperman S., Kramer J., et al. Teenagers are right-Parents do not know much: An analysis of adolescent-parent agreement on reports of adolescent substance use, abuse, and dependence. Alcoholism Clinical and Experimental Research 2006, 30:1699-1710.
18. Fordwood S.R., Asarnow J.R., Huizar D.P., Reise S.P. Suicide attempts among depressed adolescents in primary care. Journal of Clinical Child and Adolescent Psychology: The Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association. Division 53 2007, 36:392-404.
19. Fournier J.C., DeRubeis R.J., Hollon S.D., Dimidjian S., Amsterdam J.D., Shelton R.C., et al. Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA: The Journal of the American Medical Association 2010, 303:47-53.
20. Gual A., Balcells M., Torres M., Madrigal M., Diez T., Serrano L. Sertraline for the prevention of relapse in detoxicated alcohol dependent patients with a comorbid depressive disorder: A randomized controlled trial. Alcohol and Alcoholism (Oxford, Oxfordshire) 2003, 38:619-625.
21. Hedges L.V. Fixed effect models. The handbook of research synthesis 1994, 285-300. Russell Sage Foundation, New York. H. Cooper, L.V. Hedges (Eds.).
22. Keller M.B., Beardslee W., Lavori P.W., Wunder J., Drs D.L., Samuelson H. Course of major depression in non-referred adolescents: A retrospective study. Journal of Affective Disorders 1988, 15:235-243.
23. Kelly T.M., Cornelius J.R., Clark D.B. Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug and Alcohol Dependence 2004, 73:87-97.
24. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA: The Journal of the American Medical Association 2003, 289:3095-3105.
25. Kirsch I., Deacon B.J., Huedo-Medina T.B., Scoboria A., Moore T.J., Johnson B.T. Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and drug administration. PLoS Medicine 2008, 5:e45.
26. Kraemer H.C., Wilson G.T., Fairburn C.G., Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Archives of General Psychiatry 2002, 59:877-883.
27. Kranzler H.R., Mueller T., Cornelius J., Pettinati H.M., Moak D., Martin P.R., et al. Sertraline treatment of co-occurring alcohol dependence and major depression. Journal of Clinical Psychopharmacology 2006, 26:13-20.
28. Lan K.K.G., DeMets D.L. Discrete sequential boundaries for clinical trials. Biometrika 1983, 70:659-663.
29. Lan K.K.G., Wittes J. The B-value: A tool for monitoring data. Biometrics 1988, 44:579-585.
30. Langenbach T., Sponlein A., Overfeld E., Wiltfang G., Quecke N., Scherbaum N., et al. Axis I comorbidity in adolescent inpatients referred for treatment of substance use disorders. Child and Adolescent Psychiatry and Mental Health 2010, 4:25.
31. NIMH Clinical Global Impressions Scale. Psychopharmacology Bulletin 1985, 21:839-843.
32. Nunes E.V., Levin F.R. Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA: The Journal of the American Medical Association 2004, 291:1887-1896.
33. Overholser J.C., Brinkman D.C., Lehnert K.L., Ricciardi A.M. Children's depression rating scale-revised: Development of a short form. Journal of Clinical Child Psychology 1995, 24:443-452.
34. Papakostas G.I., Petersen T., Homberger C.H., Green C.H., Smith J., Alpert J.E., et al. Hopelessness as a predictor of non-response to fluoxetine in major depressive disorder. Annals of Clinical Psychiatry 2007, 19:5-8.
35. Poznanski E.O., Freeman L.N., Mokros H.B. Children's Depression Rating Scale-Revised. Psychopharmacology Bulletin 1985, 21:979-989.
36. Riggs P.D., Baker S., Mikulich S.K., Young S.E., Crowley T.J. Depression in substance-dependent delinquents. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:764-771.
37. Riggs P.D., Mikulich-Gilbertson S.K., Davies R.D., Lohman M., Klein C., Stover S.K. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Archives of Pediatrics & Adolescent Medicine 2007, 161:1026-1034.
38. Sobell L.C., Sobell M.B. Timeline followback: A technique for assessing self-reported alcohol consumption. Measuring alcohol consumption: Psychosocial and biological methods 1992, 41-72. Humana Press, Clifton, NJ. R.Z. Litten, J. Allen (Eds.).
39. Sobell M.B., Sobell L.C., Klajner F., Pavan D., Basian E. The reliability of a timeline method for assessing normal drinker college students' recent drinking history: Utility for alcohol research. Addictive Behaviors 1986, 11:149-161.
40. Tuisku V., Pelkonen M., Karlsson L., Kiviruusu O., Holi M., Ruuttu T., et al. Suicidal ideation, deliberate self-harm behaviour and suicide attempts among adolescent outpatients with depressive mood disorders and comorbid Axis I disorders. European Child & Adolescent Psychiatry 2006, 15:199-206.